This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Jerome Emile Jorges Guillemont: Innovator in Pharmaceutical Chemistry
Introduction
Jerome Emile Jorges Guillemont is a notable inventor based in Ande, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications.
Latest Patents
Guillemont holds a patent for "Quinazolinone derivatives as PARP inhibitors." This invention provides compounds of formula (I) and outlines their use as PARP inhibitors, along with pharmaceutical compositions that include these compounds. The specific meanings of R, R, R, L, X, Y, and Z are defined within the patent documentation.
Career Highlights
Guillemont is associated with Janssen Pharmaceutica NV, a prominent company in the pharmaceutical industry. His work focuses on innovative solutions for complex medical challenges, contributing to advancements in drug development.
Collaborations
He has collaborated with notable colleagues, including Ludo Edmond Josephine Kennis and Josephus Carolus Mertens. These partnerships enhance the research and development efforts within the pharmaceutical sector.
Conclusion
Jerome Emile Jorges Guillemont exemplifies the spirit of innovation in pharmaceutical chemistry through his patent on PARP inhibitors and his work at Janssen Pharmaceutica NV. His contributions are vital to the ongoing advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile